[1] KHELLAF A, KHAN DZ, HELMY A. Recent advances in traumatic brain injury. J Neurol. 2019;266(11):2878-2889.
[2] O’BRIEN WT, PHAM L, SYMONS GF, et al. The NLRP3 inflammasome in traumatic brain injury: potential as a biomarker and therapeutic target. J Neuroinflammation. 2020;17(1):104.
[3] LAN X, HAN X, LI Q, et al. Modulators of microglial activation and polarization after intracerebral haemorrhage. Nat Rev Neurol. 2017;13(7):420-433.
[4] STRATOULIAS V, VENERO JL, TREMBLAY MÈ, et al. Microglial subtypes: Diversity within the microglial community. EMBO J. 2019;38(17):e101997.
[5] BERNIER L-P, YORK EM, MACVICAR BA. Immunometabolism in the brain: How metabolism shapes microglial function. Trends Neurosci. 2020;43(11): 854-869.
[6] COLONNA M, BUTOVSKY O. Microglia function in the central nervous system during health and neurodegeneration. Annu Rev Immunol. 2017;35(1):441-468.
[7] LIU X, WU C, ZHANG Y, et al. Hyaluronan-based hydrogel integrating exosomes for traumatic brain injury repair by promoting angiogenesis and neurogenesis. Carbohydr Polym. 2023;306:120578.
[8] NOROUZI M, NAZARI B, MILLER DW. Injectable hydrogel-based drug delivery systems for local cancer therapy. Drug Discov Today. 2016;21(11):1835-1849.
[9] SUN Z, SONG C, WANG C, et al. Hydrogel-based controlled drug delivery for cancer treatment: A review. Mol Pharm. 2020;17(2):373-391.
[10] BAI L, TAO G, FENG M, et al. Hydrogel drug delivery systems for bone regeneration. Pharmaceutics. 2023;15(5):1334.
[11] KUNDU B, RAJKHOWA R, KUNDU SC, et al. Silk fibroin biomaterials for tissue regenerations. Adv Drug Deliv Rev. 2013;65(4):457-470.
[12] ROCKWOOD DN, PREDA RC, YüCEL T, et al. Materials fabrication from Bombyx mori silk fibroin. Nat Protoc. 2011;6(10):1612-1631.
[13] HE X, WANG R, ZHOU F, et al. Recent advances in photo-crosslinkable methacrylated silk (Sil-MA)-based scaffolds for regenerative medicine: A review. Int J Biol Macromol. 2023;256(Pt 1):128031.
[14] Rajput M, Mondal P, Yadav P, et al. Light-based 3D bioprinting of bone tissue scaffolds with tunable mechanical properties and architecture from photocurable silk fibroin. Int J Biol Macromol. 2022;202:644-656.
[15] WANG G, JIANG X, PU H, et al. Scriptaid, a novel histone deacetylase inhibitor, protects against traumatic brain injury via modulation of PTEN and AKT pathway. Neurotherapeutics. 2012;10(1):124-142.
[16] WANG G, SHI Y, JIANG X, et al. HDAC inhibition prevents white matter injury by modulating microglia/macrophage polarization through the GSK3β/PTEN/Akt axis. Proc Natl Acad Sci U S A. 2015;112(9):2853-2858.
[17] Black BJ, Ecker M, Stiller A, et al. In vitro compatibility testing of thiol-ene/acrylate-based shape memory polymers for use in implantable neural interfaces. J Biomed Mater Res A. 2018;106(11):2891-2898.
[18] GUTIERREZ AM, FRAZAR EM, X KLAUS MV, et al. Hydrogels and hydrogel nanocomposites: enhancing healthcare through human and environmental treatment. Adv Healthc Mater. 2022;11(7):e2101820.
[19] XU J, HSU SH. Self-healing hydrogel as an injectable implant: Translation in brain diseases. J Biomed Sci. 2023;30(1):43.
[20] ZHANG D, REN Y, HE Y, et al. In situ forming and biocompatible hyaluronic acid hydrogel with reactive oxygen species-scavenging activity to improve traumatic brain injury repair by suppressing oxidative stress and neuroinflammation. Mater Today Bio. 2022;15:100278.
[21] SALUDAS L, PASCUAL-GIL S, PRóSPER F, et al. Hydrogel based approaches for cardiac tissue engineering. Int J Pharm. 2017;523(2):454-475.
[22] WANI SUD, GAUTAM SP, QADRIE ZL, et al. Silk fibroin as a natural polymeric based bio-material for tissue engineering and drug delivery systems-A review. Int J Biol Macromol. 2020;163:2145-2161.
[23] SUBRAMANIAN A, KRISHNAN UM, SETHURAMAN S. Development of biomaterial scaffold for nerve tissue engineering: Biomaterial mediated neural regeneration. J Biomed Sci. 2009;16(1):108.
[24] HOLLISTER SJ. Porous scaffold design for tissue engineering. Nat Mater. 2005;4(7):518-524. doi:10.1038/nmat1421
[25] 谷明西,王常成,田丰德,等.丝素蛋白/明胶/壳聚糖三维多孔软骨组织支架的制备及体外评价[J]. 中国组织工程研究,2024,28(3):366-372.
[26] SHANG L, MA B, WANG F, et al. Nanotextured silk fibroin/hydroxyapatite biomimetic bilayer tough structure regulated osteogenic/chondrogenic differentiation of mesenchymal stem cells for osteochondral repair. Cell Prolif. 2020;53(11):e12917.
[27] JANAKI RAMAIAH M, NAUSHAD SM, LAVANYA A, et al. Scriptaid cause histone deacetylase inhibition and cell cycle arrest in HeLa cancer cells: A study on structural and functional aspects. Gene. 2017;627:379-386.
[28] SHARMA V, KOUL N, JOSEPH C, et al. HDAC inhibitor, scriptaid, induces glioma cell apoptosis through JNK activation and inhibits telomerase activity. J Cell Mol Med. 2009;14(8):2151-2161.
[29] WU H, ZHENG J, XU S, et al. Mer regulates microglial/macrophage M1/M2 polarization and alleviates neuroinflammation following traumatic brain injury. J Neuroinflammation. 2021;18(1):2.
[30] LI YF, REN X, ZHANG L, et al. Microglial polarization in TBI: Signaling pathways and influencing pharmaceuticals. Front Aging Neurosci. 2022;14: 901117.
[31] ORIHUELA R, MCPHERSON CA, HARRY GJ. Microglial M1/M2 polarization and metabolic states. Br J Pharmacol. 2015;173(4):649-665.
[32] DERVAN A, FRANCHI A, ALMEIDA-GONZALEZ FR, et al. Biomaterial and therapeutic approaches for the manipulation of macrophage phenotype in peripheral and central nerve repair. Pharmaceutics. 2021;13(12):2161.
[33] NAM HY, NAM JH, YOON G, et al. Ibrutinib suppresses LPS-induced neuroinflammatory responses in BV2 microglial cells and wild-type mice. J Neuroinflammation. 2018;15(1):271.
[34] GU C, WANG F, ZHANG YT, et al. Microglial MT1 activation inhibits LPS‐induced neuroinflammation via regulation of metabolic reprogramming. Aging Cell. 2021;20(6):e13375.
[35] WANG Y, WANG K, FU J. HDAC6 mediates macrophage iNOS expression and excessive nitric oxide production in the blood during endotoxemia. Front Immunol. 2020;11:1893.
[36] BAIER J, GÄNSBAUER M, GIESSLER C, et al. Arginase impedes the resolution of colitis by altering the microbiome and metabolome. J Clin Invest. 2020; 130(11):5703-5720.
|